MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
19.79
+1.28 (6.92%)
At close: Mar 9, 2026, 4:00 PM EDT
19.83
+0.04 (0.18%)
After-hours: Mar 9, 2026, 4:10 PM EDT

MapLight Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22
Market Capitalization
864---
Enterprise Value
643---
Debt / Equity Ratio
0.030.060.080.30
Net Debt / Equity Ratio
-0.95-0.89-1.04-1.02
Net Debt / EBITDA Ratio
2.051.241.300.70
Net Debt / FCF Ratio
1.961.281.410.78
Quick Ratio
12.246.835.432.20
Current Ratio
13.227.205.692.54
Return on Equity (ROE)
--83.21%-120.91%-
Return on Assets (ROA)
--45.41%-54.74%-
Return on Capital Employed (ROCE)
-45.50%-68.60%-74.70%-116.60%
Buyback Yield / Dilution
-15.66%-11.60%-18.43%-
Source: S&P Capital IQ. Standard template. Financial Sources.